Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 62 Records) |
| Query Trace: Hepatitis A and meta-analysis and HCC[original query] |
|---|
| Association between HLA-DQ Gene Polymorphisms and HBV-Related Hepatocellular Carcinoma. Gastroenterology research and practice 2017 2017 7150386. Lv Jingzhu, Xu Tao, Qian Zhongqing, Wang Hongt |
| Meta-analysis of the correlation between the rs17401966 polymorphism in kinesin family member 1B and susceptibility to hepatitis B virus related hepatocellular carcinoma. Clinical and molecular hepatology 2017 Apr . Su Mingkuan, Guo Jianfeng, Huang Jianche |
| Association of PNPLA3 rs738409 polymorphism with liver steatosis but not with cirrhosis in patients with HBV infection: Systematic review with meta-analysis. The journal of gene medicine 2017 Dec . Ghalamkari Saman, Sharafi Heidar, Alavian Seyed Moay |
| Genetic variations of NTCP are associated with susceptibility to HBV infection and related hepatocellular carcinoma. Oncotarget 2017 Dec 8 (62): 105407-105424. Wang Peng, Mo Ruidong, Lai Rongtao, Xu Yumin, Lu Jie, Zhao Gangde, Liu Yuhan, Cao Zhujun, Wang Xiaolin, Li Ziqiang, Lin Lanyi, Zhou Huijuan, Cai Wei, Wang Hui, Bao Shisan, Xiang Xiaogang, Xie Qi |
| Association of GSTP1 and P16 promoter methylation with the risk of HBV-related hepatocellular carcinoma: a meta-analysis. OncoTargets and therapy 2018 9 11 5789-5796. Li Qin, Deng Cunliang, Zhang Ting, Li Xia |
| Comprehensive assessment for miRNA polymorphisms in hepatocellular cancer risk: a systematic review and meta-analysis. Bioscience reports 2018 Jul . Wang Ben-Gang, Jiang Li-Yue, Xu Qi |
| MiR-499 rs3746444 polymorphism and hepatocellular carcinoma risk: A meta-analysis. Journal of cancer research and therapeutics 2018 Jun 14 (Supplement): S490-S493. Qiu Dapeng, Han Feng, Zhuang H |
Genome-wide association study identified new susceptible genetic variants in HLA class I region for hepatitis B virus-related hepatocellular carcinoma.
Scientific reports 2018 May 8 (1): 7958. Sawai Hiromi, Nishida Nao, Khor Seik-Soon, Honda Masao, Sugiyama Masaya, Baba Natsumi, Yamada Kayoko, Sawada Norie, Tsugane Shoichiro, Koike Kazuhiko, Kondo Yuji, Yatsuhashi Hiroshi, Nagaoka Shinya, Taketomi Akinobu, Fukai Moto, Kurosaki Masayuki, Izumi Namiki, Kang Jong-Hon, Murata Kazumoto, Hino Keisuke, Nishina Sohji, Matsumoto Akihiro, Tanaka Eiji, Sakamoto Naoya, Ogawa Koji, Yamamoto Kazuhide, Tamori Akihiro, Yokosuka Osamu, Kanda Tatsuo, Sakaida Isao, Itoh Yoshito, Eguchi Yuichiro, Oeda Satoshi, Mochida Satoshi, Yuen Man-Fung, Seto Wai-Kay, Poovorawan Yong, Posuwan Nawarat, Mizokami Masashi, Tokunaga Katsus |
| Quantitative assessment of HLA-DQ gene polymorphisms with the development of hepatitis B virus infection, clearance, liver cirrhosis, and hepatocellular carcinoma. Oncotarget 2018 2 9 (1): 96-109. Xu Tao, Zhu Anyou, Sun Meiqun, Lv Jingzhu, Qian Zhongqing, Wang Xiaojing, Wang Ting, Wang Hongt |
| Association of cytotoxic T-lymphocyte antigen-4 + 49A/G gene polymorphism with hepatocellular carcinoma risk in Chinese. Journal of cancer research and therapeutics 2018 Dec 14 (Supplement): S1117-S1120. Wang Cunchuan, Liu Weimin, Zhao Lei, Dong Zhiyo |
| Relationship between the rs2596542 polymorphism in the MICA gene promoter and HBV/HCV infection-induced hepatocellular carcinoma: a meta-analysis. BMC medical genetics 2019 Aug 20 (1): 142. Luo Xiaojun, Wang Yu, Shen Ai, Deng Hejun, Ye M |
| The roles of transmembrane 6 superfamily member 2 rs58542926 polymorphism in chronic liver disease: A meta-analysis of 24,147 subjects. Molecular genetics & genomic medicine 2019 Jul e824. Chen Xinpei, Zhou Pengcheng, De Luo, Li Bo, Su So |
| Association of STAT3 and STAT4 polymorphisms with susceptibility to chronic hepatitis B virus infection and risk of hepatocellular carcinoma: a meta-analysis. Bioscience reports 2019 Jun . Shi Han, He Hongyan, Ojha Suvash Chandra, Sun Changfeng, Fu Juan, Yan Mao, Deng Cunliang, Sheng Yunji |
| Association between KIF1B rs17401966 genetic polymorphism and hepatocellular carcinoma susceptibility: an updated meta-analysis. BMC medical genetics 2019 Apr 20 (1): 59. Luo Ying-Ying, Zhang Hong-Peng, Huang Ai-Long, Hu Jie- |
| GSTM1 and GSTT1 null genotype increase the risk of hepatocellular carcinoma: evidence based on 46 studies. Cancer cell international 2019 19 76. Li Shanli, Xue Feng, Zheng Yi, Yang Pengtao, Lin Shuai, Deng Yujiao, Xu Peng, Zhou Linghui, Hao Qian, Zhai Zhen, Wu Ying, Dai Zhijun, Chen S |
| The influence of interleukin 28B polymorphisms on the risk of hepatocellular carcinoma among patients with HBV or HCV infection: An updated meta-analysis. Medicine 2019 Sep 98 (38): e17275. Qin Shaoyou, Wang Jiangbin, Zhou Changyu, Xu Yan, Zhang Yonggui, Wang Xu, Wang So |
| Meta-analysis: Association between hepatitis B virus preS mutation and hepatocellular carcinoma risk. Journal of viral hepatitis 2020 9 28 (1): 61-71. Wungu Citrawati Dyah Kencono, Ariyanto Fis Citra, Prabowo Gwenny Ichsan, Soetjipto Soetjipto, Handajani Ret |
| PNPLA3 rs738409 is not associated with the risk of hepatocellular carcinoma and persistent infection of hepatitis B virus (HBV) in HBV-related subjects: A case-control study and meta-analysis on Asians. Gene 2020 3 742 144585. Wang Peng, Wu Chunxi, Li Ying, Gong Yajie, Shen |
| Methylenetetrahydrofolate reductase C677T (Ala>Val, rs1801133 C>T) polymorphism decreases the susceptibility of hepatocellular carcinoma: a meta-analysis involving 12,628 subjects. Bioscience reports 2020 Feb . Zhang Sheng, Jiang Jiakai, Tang Weifeng, Liu Longg |
| MBOAT7-TMC4 rs641738 Is Not Associated With the Risk of Hepatocellular Carcinoma or Persistent Hepatitis B Infection. Frontiers in oncology 2021 11 639438. Wang Peng, Li Ying, Li Lu, Zhong Rong, Shen |
| Variation and expression of HLA-DPB1 gene in HBV infection. Immunogenetics 2021 Mar . Ou Guojin, Liu Xiao, Xu Haixia, Ji Xin, Liu Xiaojuan, Wang J |
| MiRNA Polymorphisms and Hepatocellular Carcinoma Susceptibility: A Systematic Review and Network Meta-Analysis. Frontiers in oncology 2021 2 10 562019. Zhang Qimeng, Xu Xueying, Wu Mingcheng, Qin Tiantian, Wu Shaoning, Liu Hong |
| The rs429358 Locus in Apolipoprotein E Is Associated With Hepatocellular Carcinoma in Patients With Cirrhosis. Hepatology communications 2021 12 6 (5): 1213-1226. Innes Hamish, Nischalke Hans Dieter, Guha Indra Neil, Weiss Karl Heinz, Irving Will, Gotthardt Daniel, Barnes Eleanor, Fischer Janett, Ansari M Azim, Rosendahl Jonas, Lin Shang-Kuan, Marot Astrid, Pedergnana Vincent, Casper Markus, Benselin Jennifer, Lammert Frank, McLauchlan John, Lutz Philip L, Hamill Victoria, Mueller Sebastian, Morling Joanne R, Semmler Georg, Eyer Florian, von Felden Johann, Link Alexander, Vogel Arndt, Marquardt Jens U, Sulk Stefan, Trebicka Jonel, Valenti Luca, Datz Christian, Reiberger Thomas, Schafmayer Clemens, Berg Thomas, Deltenre Pierre, Hampe Jochen, Stickel Felix, Buch Steph |
| Association of HSD17B13 rs72613567: TA allelic variant with liver disease: review and meta-analysis. BMC gastroenterology 2021 12 21 (1): 490. Tang Shan, Zhang Jing, Mei Ting-Ting, Zhang Wen-Yan, Zheng Su-Jun, Yu Hai-B |
| The combined signatures of hypoxia and cellular landscape provides a prognostic and therapeutic biomarker in hepatitis B virus-related hepatocellular carcinoma. International journal of cancer 2022 4 151 (5): 809-824. Chen Shipeng, Gao Yuzhen, Wang Ying, Daemen To |
| The relationship between NTCP gene varieties and the progress of liver disease after HBV infection: an updated systematic review and meta-analysis. The American journal of the medical sciences 2022 4 364 (2): 207-219. He Chuan, He Hong-Yan, Sun Chang-Feng, Ojha Suvash Chandra, Wang Hang, Deng Cun-Liang, Sheng Yun-Ji |
| Treatment Outcomes of Sofosbuvir/Velpatasvir/Voxilaprevir in Direct-Acting Antiviral-Experienced Hepatitis C Virus Patients: A Systematic Review and Meta-Analysis. Viruses 2023 7 15 (7): . Pooja Devan, Kai Le Ashley Tiong, Jean Ee Neo, Babu P Mohan, Karn Wijarnpreecha, Yew Chong Steve Tam, Nicola Coppola, Carmen Monica Preda, Yu Jun Wo |
| Hepatitis E virus infection and risk of hepatocellular carcinoma: A systematic review and meta-analysis. Cancer epidemiology 2023 10 87 102457. Xia Yin, Fanggong K |
| Associations between modifiable risk factors and hepatocellular carcinoma: a trans-ancestry Mendelian randomization study. BMC cancer 2024 7 24 (1): 820. Xiaoxia Wei, Chenglei Yang, Qiuling Lin, Moqin Qiu, Qiuping Wen, Zihan Zhou, Yanji Jiang, Peiqin Chen, Xiumei Liang, Ji Cao, Juan Tang, Yuying Wei, Hongping Yu, Yingchun L |
| Leptin receptor Gln223Arg and Lys109Arg polymorphisms may be associated with HBV-related hepatocellular carcinoma risk: A system review and meta-analysis. Environmental toxicology 2024 4 . Xiaofeng Dong, Mengjie Zou, Chunxing Li, Honglin Luo, Shaoliang Zhu, Zheng Go |
- Page last reviewed:Feb 1, 2024
- Content source: